Eli Lilly
LLY
#15
Rank
$700.83 B
Marketcap
$780.67
Share price
0.18%
Change (1 day)
-14.64%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

Eli Lilly (LLY) - P/B ratio

P/B ratio as of July 2025 : 44.2

According to Eli Lilly's latest financial reports the company has a price-to-book ratio of 14.3018.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eli Lilly - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-3149.4-3.11%
2023-12-3150.957.9%
2022-12-3132.311.77%
2021-12-3128.94.1%
2020-12-3127.7-40.54%
2019-12-3146.6315.59%
2018-12-3111.240.76%
2017-12-317.9738.22%
2016-12-315.77-9.66%
2015-12-316.3828.19%
2014-12-314.9854.22%
2013-12-313.23-15.64%
2012-12-313.837.67%
2011-12-313.559.29%
2010-12-313.25-24.49%
2009-12-314.31-36.61%
2008-12-316.8051.52%
2007-12-314.48-16.48%
2006-12-315.37-9.39%
2005-12-315.930.74%
2004-12-315.88-27.32%
2003-12-318.09-6.05%
2002-12-318.61

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Bristol-Myers Squibb
BMY
5.47-87.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.20-90.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
4.81-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.59-96.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.49-96.63%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
4.44-89.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
229 417.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
25.8-41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.28-85.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AstraZeneca
AZN
5.38-87.83%๐Ÿ‡ฌ๐Ÿ‡ง UK